• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Neuroendocrine Carcinoma Global Clinical Trials Review, Q1, 2011 - Product Image

Neuroendocrine Carcinoma Global Clinical Trials Review, Q1, 2011

  • Published: January 2011
  • Region: Global
  • 59 Pages
  • GlobalData

Neuroendocrine Carcinoma Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, Q1, 2011" provides data on the Neuroendocrine Carcinoma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Neuroendocrine Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Neuroendocrine Carcinoma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with READ MORE >



List of Tables
List of Figures
Introduction
Neuroendocrine Carcinoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Neuroendocrine Carcinoma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Neuroendocrine Carcinoma Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Ipsen Limited
Clinical Trial Overview of Ipsen Limited
Novartis AG
Clinical Trial Overview of Novartis AG
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Callisto Pharmaceuticals, Inc.
Clinical Trial Overview of Callisto Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc.
Clinical Trial Overview of Molecular Insight Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc.
Clinical Trial Overview of Cylene Pharmaceuticals, Inc.
Neotropix, Inc.
Clinical Trial Overview of Neotropix, Inc.
iOMEDICO AG
Clinical Trial Overview of iOMEDICO AG
MannKind Corporation
Clinical Trial Overview of MannKind Corporation
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
National Cancer Institute (NCI)
Clinical Trial Overview of National Cancer Institute (NCI)
Stanford University
Clinical Trial Overview of Stanford University
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
The University of Iowa
Clinical Trial Overview of The University of Iowa
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
The University of Western Ontario
Clinical Trial Overview of The University of Western Ontario
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
University of Turin
Clinical Trial Overview of University of Turin
Tel-Aviv Sourasky Medical Center
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
University Hospital Inselspital, Berne
Clinical Trial Overview of University Hospital Inselspital, Berne
Assistance Publique Hopitaux De Marseille
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille
Columbia University
Clinical Trial Overview of Columbia University
Eastern Cooperative Oncology Group
Clinical Trial Overview of Eastern Cooperative Oncology Group
Samsung Medical Center
Clinical Trial Overview of Samsung Medical Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
University of New Mexico
Clinical Trial Overview of University of New Mexico
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Asia-Pacific ,Top Countries, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, BRIC Countries, 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Terminated Clinical Trials, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen Limited, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Callisto Pharmaceuticals, Inc., 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Molecular Insight Pharmaceuticals, Inc., 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cylene Pharmaceuticals, Inc., 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Neotropix, Inc., 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by iOMEDICO AG, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Iowa, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Western Ontario, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Turin, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of New Mexico, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2011-

List of Figures
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Neuroendocrine Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Neuroendocrine Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010-
Methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos